Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6448419 | 1.00 | NPC1 (0.32) | NPC1GAARAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL16056817 | 0.77 | DGAT1 (0.32) | — | |
| SCHEMBL30000700 | 0.75 | MEN1 (0.35) | NPC1GAARAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL31276810 | 0.73 | MEN1 (0.34) | NPC1GAARAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL3664914 | 0.72 | CES1 (0.45) | NPC1GAARAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL6448270 | 0.72 | NPC1 (0.33) | NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL6448268 | 0.72 | NPC1 (0.33) | NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL6445727 | 0.72 | MEN1 (0.44) | LMNA | |
| SCHEMBL6445644 | 0.69 | LMNA (0.33) | SMN1; SMN2LMNA | |
| SCHEMBL23302243 | 0.68 | SMN1; SMN2 (0.35) | NPC1GAARAB9ASMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220166105-A1 | LITHIUM SECONDARY BATTERY INCLUDING SEPARATOR WITH CERAMIC LAYER HAVING FIRST CERAMIC PARTICLE BONDED TO SECOND CERAMIC PARTICLE AND MANUFACTURING METHOD THE SAME | KIA CORPORATION (KR) | 2022-05-26 | — | — | US | claimed |
| US-20200194760-A1 | LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF | KIA MOTORS CORPORATION (KR) | 2020-06-18 | — | — | US | claimed |
| US-12170350-B2 | Lithium secondary battery including separator with ceramic layer having first ceramic particle bonded to second ceramic particle and manufacturing method the same | HYUNDAI MOTOR COMPANY (KR) | 2024-12-17 | — | — | US | disclosed |
| US-20220166105-A1 | LITHIUM SECONDARY BATTERY INCLUDING SEPARATOR WITH CERAMIC LAYER HAVING FIRST CERAMIC PARTICLE BONDED TO SECOND CERAMIC PARTICLE AND MANUFACTURING METHOD THE SAME | KIA CORPORATION (KR) | 2022-05-26 | — | — | US | disclosed |
| US-11289768-B2 | Lithium secondary battery including separator with ceramic layer having first ceramic particle bonded to second ceramic particle and manufacturing method the same | HYUNDAI MOTOR COMPANY (KR) | 2022-03-29 | — | — | US | disclosed |
| US-20200194760-A1 | LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF | KIA MOTORS CORPORATION (KR) | 2020-06-18 | — | — | US | disclosed |
| US-6921832-B2 | Optically active fluorine-containing compounds and processes for their production | TOSOH CORPORATION (JP) | 2005-07-26 | — | — | US | disclosed |
| US-20040147756-A1 | Optically active fluorine-containing compounds and processes for their production | TOSOH CORPORATION (JP) | 2004-07-29 | — | — | US | disclosed |
| EP-1422226-A1 | Optically active fluorine-containing compounds and processes for their production | Tosoh Corporation (JP) | 2004-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147756-A1 | Optically active fluorine-containing compounds and processes for their production | CYP2C19, CYP2F1, CYP2B6 | NPC1 399/4885GAA 3002/4885RAB9A 465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.